BrainStorm Cell Therapeutics
BCLI
#10103
Rank
A$11.35 M
Marketcap
$1.74
Share price
14.87%
Change (1 day)
-85.94%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : A$14.91 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's total liabilities are A$14.91 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BrainStorm Cell Therapeutics - Total liabilities on balance sheet (from 2002 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31A$16.84 M22.95%
2021-12-31A$13.7 M-33.29%
2020-12-31A$20.54 M-23.32%
2019-12-31A$26.79 M203.82%
2018-12-31A$8.81 M24.2%
2017-12-31A$7.1 M492.35%
2016-12-31A$1.19 M-70.42%
2015-12-31A$4.05 M2.48%
2014-12-31A$3.95 M77.5%
2013-12-31A$2.22 M100.25%
2012-12-31A$1.11 M-9.19%
2011-12-31A$1.22 M-19.62%
2010-12-31A$1.52 M-45.24%
2009-12-31A$2.78 M-33.46%
2008-12-31A$4.18 M4.16%
2007-12-31A$4.01 M24.68%
2006-12-31A$3.22 M
2006-03-31A$12.42 M5388.37%
2005-03-31A$0.22 M257.86%
2004-03-31A$0.06 M51.88%
2003-03-31A$0.04 M93.43%
2002-03-31A$0.02 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$61.78 B 414,124.68%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.38 B 15,917.51%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.68 B 11,194.71%๐Ÿ‡บ๐Ÿ‡ธ USA
A$17.61 B 118,004.42%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.82 B 5,451.22%๐Ÿ‡บ๐Ÿ‡ธ USA